# BoB@JPM: Ron Cooper, enGene

Page: https://stenobird.com/podcast/business-of-biotech-123501/bob-jpm-ron-cooper-engene
Text version: https://stenobird.com/podcast/business-of-biotech-123501/bob-jpm-ron-cooper-engene.md
Podcast: [Business Of Biotech](https://stenobird.com/podcast/business-of-biotech-123501)
Published: 2026-01-26T11:00:00+00:00
Episode link: https://www.buzzsprout.com/1011661/episodes/18546471-bob-jpm-ron-cooper-engene.mp3
Audio file: https://www.buzzsprout.com/1011661/episodes/18546471-bob-jpm-ron-cooper-engene.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/bob-jpm-ron-cooper-engene
Duration seconds: 3357

## Resource

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech -- on location at the J.P. Morgan Healthcare Conference -- we're speaking with Ron Cooper, CEO and Board Member at enGene, to unpack how he scaled Albireo from a small research shop to a global commercial company, and why he’s now betting on nonviral gene therapy at enGene to help patients with non-muscle invasive bladder cancer keep their bladders. Cooper talks about the importance of ke...

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/bob-jpm-ron-cooper-engene/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/business-of-biotech-123501/bob-jpm-ron-cooper-engene.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.